全文获取类型
收费全文 | 1751篇 |
免费 | 80篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 102篇 |
妇产科学 | 27篇 |
基础医学 | 157篇 |
口腔科学 | 33篇 |
临床医学 | 109篇 |
内科学 | 401篇 |
皮肤病学 | 44篇 |
神经病学 | 43篇 |
特种医学 | 114篇 |
外科学 | 264篇 |
综合类 | 144篇 |
预防医学 | 58篇 |
眼科学 | 41篇 |
药学 | 133篇 |
中国医学 | 63篇 |
肿瘤学 | 98篇 |
出版年
2023年 | 16篇 |
2022年 | 27篇 |
2021年 | 75篇 |
2020年 | 30篇 |
2019年 | 38篇 |
2018年 | 66篇 |
2017年 | 37篇 |
2016年 | 49篇 |
2015年 | 46篇 |
2014年 | 64篇 |
2013年 | 95篇 |
2012年 | 97篇 |
2011年 | 100篇 |
2010年 | 75篇 |
2009年 | 64篇 |
2008年 | 78篇 |
2007年 | 69篇 |
2006年 | 79篇 |
2005年 | 66篇 |
2004年 | 58篇 |
2003年 | 53篇 |
2002年 | 47篇 |
2001年 | 44篇 |
2000年 | 44篇 |
1999年 | 39篇 |
1998年 | 35篇 |
1997年 | 29篇 |
1996年 | 35篇 |
1995年 | 20篇 |
1994年 | 32篇 |
1993年 | 10篇 |
1992年 | 11篇 |
1991年 | 5篇 |
1990年 | 14篇 |
1989年 | 14篇 |
1988年 | 22篇 |
1987年 | 20篇 |
1986年 | 19篇 |
1985年 | 18篇 |
1984年 | 10篇 |
1983年 | 14篇 |
1982年 | 9篇 |
1981年 | 11篇 |
1980年 | 8篇 |
1979年 | 10篇 |
1978年 | 6篇 |
1977年 | 7篇 |
1976年 | 4篇 |
1975年 | 7篇 |
1965年 | 2篇 |
排序方式: 共有1838条查询结果,搜索用时 31 毫秒
1.
In both adults and children with diabetes, technologies such as continuous subcutaneous insulin infusion using insulin pumps and continuous glucose monitoring can help improve diabetes control, reduce hypoglycaemia and improve quality of life. Access to these technologies in the UK is very variable. Some technologies are recommended by the National Institute for Health and Care Excellence, while others have not been appraised, and new technologies are emerging all the time. Additionally, different guidelines for adults and children further complicate access to diabetes technology in the transition from paediatric to adult care. Against this background, Diabetes UK and NHS England have brought together a multidisciplinary group of experts, including clinicians and people with diabetes, to develop this consensus guideline, combining the different technologies into a common pathway to aid clinical and policy decision‐making. We created a pathway that supports the incremental addition of technology as monotherapy and then dual therapy in the same way that we incrementally add in therapeutic agents to support people with Type 2 diabetes to achieve their personalized glycaemic targets. The pathway emphasizes the importance of structured education, specialist support and appropriate access to psychological therapies, as essential pillars for optimized use of diabetes‐related technology, and recommends the re‐evaluation of its use when the individual is unable either to use the technology appropriately or to achieve the intended outcomes. This pathway is endorsed by UK‐wide clinical and patient associations and we recommend that providers and commissioners use it to ensure the right individual with diabetes has access to the right technology in a timely way to help achieve better outcomes. 相似文献
2.
3.
4.
5.
6.
7.
HERMAN TOURNAYE RONNY JANSSENS PAUL DEVROEY RK VAN STEIRTEGHEM 《International journal of andrology》1994,17(1):1-8
In order to evaluate the effects of pentoxifylline on sperm motility and longevity, a controlled in-vitro study was conducted on normozoospermic donor semen samples using the Cellsoft automated system for sperm motility analysis. After incubation and selection, pentoxifylline was found to improve the recovery of spermatozoa and to increase their velocity. In the subgroup of progressively motile spermatozoa, curvilinear velocity was also enhanced. It is concluded that pentoxifylline has an effect on the vigour, but not on the pattern, of sperm motion. Pentoxifylline did not improve the motility characteristics of senescent spermatozoa in normozoospermic sperm samples. Sperm survival, as shown by supra-vital staining, and motility longevity both decreased with time after pentoxifylline treatment. 相似文献
8.
9.
V. JNSSON H. D. SCHRDER W. TROJABORG T. STAEHELIN JENSEN E. HIPPE M. MRK HANSEN 《Journal of internal medicine》1992,232(2):185-191
A study of 17 patients with autoimmune axonal or demyelinating peripheral neuropathy in combination with M-component is described. The M-component was associated with MGUS (monoclonal gammopathy of undetermined significance) in 12 patients, CLL in one patient, WaldenstrÖm's disease in one patient, and myeloma in three patients. Immunohistological examination with direct and indirect fluorescence showed binding of antibodies to nerve structures of the same class and light chain as seen in the M-component. In five cases of IgM M-component, the demyelinating neuropathy was caused by binding of the IgM M-protein and complement C3b to myelin-associated glycoproteins (MAG). In 12 cases with axonal neuropathy, binding of IgG to the connective tissue of the peri- and endoneurium was found in 50% of cases, IgM in five cases, and IgD in one case. None of the patients had central nervous system (CNS) symptoms. The clinical and therapeutic difficulties are discussed; only two patients with an acute course responded to immunosuppression. A marked co-expression of other autoimmune phenomena is interpreted in the light of cross-reactions between the autoantibody and similar tissue autoantigens. 相似文献
10.